- Report
- September 2026
- 184 Pages
Global
From €3344EUR$3,545USD£2,805GBP
€3715EUR$3,939USD£3,117GBP
- Report
- September 2026
- 199 Pages
Global
From €3344EUR$3,545USD£2,805GBP
€3715EUR$3,939USD£3,117GBP
- Report
- November 2026
- 392 Pages
Global
From €5518EUR$5,850USD£4,629GBP
- Report
- February 2026
- 250 Pages
Global
From €4235EUR$4,490USD£3,553GBP
- Report
- February 2026
- 306 Pages
Global
From €2358EUR$2,500USD£1,978GBP
- Report
- November 2026
- 160 Pages
Global
From €3132EUR$3,320USD£2,627GBP
€3914EUR$4,150USD£3,284GBP
- Report
- February 2026
- 250 Pages
Global
From €4235EUR$4,490USD£3,553GBP
- Report
- November 2026
- 160 Pages
Global
From €3132EUR$3,320USD£2,627GBP
€3914EUR$4,150USD£3,284GBP
- Report
- August 2026
- 160 Pages
Global
From €3132EUR$3,320USD£2,627GBP
€3914EUR$4,150USD£3,284GBP
- Report
- June 2026
- 200 Pages
Global
From €2820EUR$2,990USD£2,366GBP
- Report
- September 2026
- 197 Pages
Global
From €3344EUR$3,545USD£2,805GBP
€3715EUR$3,939USD£3,117GBP
- Report
- September 2026
- 185 Pages
Global
From €3344EUR$3,545USD£2,805GBP
€3715EUR$3,939USD£3,117GBP
- Report
- September 2026
- 182 Pages
Global
From €3344EUR$3,545USD£2,805GBP
€3715EUR$3,939USD£3,117GBP
- Report
- September 2026
- 194 Pages
Global
From €3344EUR$3,545USD£2,805GBP
€3715EUR$3,939USD£3,117GBP
- Report
- September 2026
- 189 Pages
Global
From €3344EUR$3,545USD£2,805GBP
€3715EUR$3,939USD£3,117GBP
- Report
- November 2026
- 389 Pages
Global
From €5518EUR$5,850USD£4,629GBP
- Report
- February 2026
- 250 Pages
Global
From €4235EUR$4,490USD£3,553GBP
- Report
- January 2026
- 185 Pages
Global
From €4245EUR$4,500USD£3,561GBP
- Report
- August 2025
- 200 Pages
United States
From €2349EUR$2,490USD£1,970GBP
- Report
- May 2025
- 200 Pages
Global
From €2349EUR$2,490USD£1,970GBP

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that affects millions of people worldwide. It is characterized by difficulty breathing, coughing, and wheezing. COPD is typically treated with a combination of medications, including bronchodilators, inhaled corticosteroids, and antibiotics. The COPD drug market is a subset of the larger respiratory drug market, which includes drugs used to treat asthma, allergies, and other respiratory conditions.
The COPD drug market is highly competitive, with a variety of companies offering different types of medications. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novartis, and Merck. These companies offer a range of COPD medications, including bronchodilators, inhaled corticosteroids, and antibiotics. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of these medications. Show Less Read more